Showing results (461-470 of 538) with videos related to
Sort By:
Pageof 54
Antimicrobial Agents and Chemotherapy|February 14, 2018
The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitisNathan P Wiederhold, Lisa F Shubitz, Laura K Najvar, et al.Medical Mycology|April 8, 2010
Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patientSteven D Westbrook, Nathan P Wiederhold, Ana C Vallor, et al.Antimicrobial Agents and Chemotherapy|December 12, 2018
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates In Vitro and In Vivo Activity against Candida aurisNathan P Wiederhold, Shawn R Lockhart, Laura K Najvar, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 6, 2008
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosisD P Kontoyiannis, V Ratanatharathorn, J-A Young, et al.Journal of Clinical Microbiology|January 22, 2016
Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal ModelP Lewis White, Nathan P Wiederhold, Juergen Loeffler, et al.Journal of Clinical Microbiology|November 24, 1999
Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancerS W Redding, R C Zellars, W R Kirkpatrick, et al.Open Forum Infectious Diseases|July 18, 2025
COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis-Results of the Prospective MSG-017 StudyM Hong Nguyen, Sixto M Leal, Luis Ostrosky-Zeichner, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcomeThomas F Patterson, Helen W Boucher, Raoul Herbrecht, et al.Journal of Clinical Microbiology|September 17, 1998
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolatesW R Kirkpatrick, S G Revankar, R K Mcatee, et al.Clinical Microbiology Reviews|July 13, 2023
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and ManagementGeorge R Thompson, Jeffrey D Jenks, John W Baddley, et al.Pageof 54